Brief Introduction

BrightGene Bio-Medical Technology Co., Ltd. Is founded in 2001, The company is a research driven and technology platform-based enterprise, engages in international competition of the whole industry chain of chemical drugs, and has formed continuous profit model covering the whole industry chain including "starting materials-intermediates with high technical difficulty-distinctive APIs-drug products".

Company Overview

Full name BrightGene Bio-Medical Technology Co.,Ltd.
Abbreviations BrightGene
Code 688166
Founded 2001-10-26
Listing 2019-11-08
Domicile Suzhou
Website http://www.bright-gene.com
Email IR@bright-gene.com
STAR Theme Biomedicine
CSRC Sector Manufacturing
Has weighted voting rights structure? No

Financials

Highlights

  2020 2019 2018
Earnings Per Share 0.41 0.30 0.21
R&D expenditure as a % of operating revenue 17.93% 24.82% 23.59%
Operating Revenue 785.38 503.16 407.50
Net Income 169.36 111.08 73.20

Income Statement (Unit: RMB mn)

  2020 2019 2018
Operating Revenue 785.38 503.16 407.50
Operating Costs 598.41 382.00 323.97
Operating Income 193.06 121.33 81.84
Pretax Income 191.32 119.94 79.22
Income Tax 21.96 8.86 6.02
Net Income 169.36 111.08 73.20

Balance Sheet(Unit: RMB mn)

  2020 2019 2018
Assets
Current Assets-Total 946.36 1,062.05 562.81
Non-current Assets-Total 881.42 359.25 312.52
Total Assets 1,827.79 1,421.30 875.33
Liabilities
Current Liabilities-Total 291.71 108.21 105.52
Non-current Liabilities-Total 103.52 0 0
Total Liabilities 395.23 108.21 105.52
Stockholder's Equity
Share Capital 1,111.01 1,111.01 671.03
Retained Profits 320.77 202.07 98.78
Minority Interests 0.78 0 0
Total Owners' Equity 1,432.56 1,313.09 769.80

Cash Flow Statement (Unit: RMB mn)

  2020 2019 2018
Net Cash Flows-Operating 155.43 61.33 63.99
Net Cash Flows-Investing -541.92 -155.99 -212.48
Net Cash Flows-Financing 185.73 439.76 249.59

Top 10 Shareholders

Name No. of Shares Held (mn) % of Shares Held
Jiandong Yuan 113.53 27.69%
Weifang Zhong 39.19 9.56%
苏州博瑞鑫稳管理咨询合伙企业(有限合伙) 35.25 8.60%
宁波梅山保税港区红杉智盛股权投资合伙企业(有限合伙) 28.72 7.01%
先进制造产业投资基金(有限合伙) 18.61 4.54%
宁波保税区弘鹏股权投资合伙企业(有限合伙) 12.98 3.17%
南京华泰大健康一号股权投资合伙企业(有限合伙) 12.85 3.14%
苏州高铨创业投资企业(有限合伙) 7.62 1.86%
广发乾和投资有限公司 7.47 1.82%
苏州德睿亨风创业投资有限公司 7.12 1.74%
31 Dec 2020

Legal Statement

All information contained herein is provided by the underlying company itself and is for informational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. The Shanghai Stock Exchange does not guarantee its accuracy and reliability and shall under no circumstance be responsible or liable for any error or for any loss directly or indirectly arising from any inaccuracy or omission or from any decision, action or non-action based on or in reliance upon the information herein.

Users may view and download the information herein for personal and non-commercial use free of charge subject to the laws of the People's Republic of China and the Legal Statement. No part of the information herein may be copied, downloaded, stored in a retrieval system or transmitted in any form or by any means, rented, displayed, performed, reproduced, photocopied, altered, sold, broadcast, published or otherwise in whole or in part in any manner for commercial purposes, without the prior written consent of the Shanghai Stock Exchange.

Users are hereby reminded that the Legal Statement represents your legally binding agreement with the Shanghai Stock Exchange. By accessing or using this website, you are also signifying your agreement with and acceptance of all the contents in the Legal Statement. The Shanghai Stock Exchange reserves the right to amend and interpret the Legal Statement.